首页> Health affairs (Project Hope)> Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.

导出原文传递

翻译打印收藏纠错

第一作者： So Yoon,Sim

第一单位： So Yoon Sim is a technical officer in the Department of Immunization, Vaccines, and Biologicals at the World Health Organization, in Geneva, Switzerland. She was a health economist and research associate in the Department of International Health, Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland, when this work was performed. Sim and Elizabeth Watts share credit as co-first authors.

作者： So Yoon,Sim ^[1] ; Elizabeth,Watts ^[2] ; Dagna,Constenla ^[3] ; Logan,Brenzel ^[4] ; Bryan N,Patenaude ^[5]

作者单位： So Yoon Sim is a technical officer in the Department of Immunization, Vaccines, and Biologicals at the World Health Organization, in Geneva, Switzerland. She was a health economist and research associate in the Department of International Health, Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland, when this work was performed. Sim and Elizabeth Watts share credit as co-first authors. ^[1] Elizabeth Watts (ewatts13@jhmi.edu) is a health economist and research associate in the Department of International Health and in the International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. Watts and So Yoon Sim share credit as co-first authors. ^[2] Dagna Constenla is the director of Epidemiology and Health Outcomes at GSK Vaccines, Latin America and the Caribbean, in Panama City, Panama. She was an associate scientist in the Department of International Health, Johns Hopkins Bloomberg School of Public Health, when this work was performed. ^[3] Logan Brenzel is a senior program officer for economics and finance, Vaccine Delivery/Global Development, Bill & Melinda Gates Foundation, in Washington, D.C. ^[4] Bryan N. Patenaude is an assistant professor in the Department of International Health, Johns Hopkins Bloomberg School of Public Health. ^[5]

关键词 Caregivers Cost of illness analysis Costs and spending Diseases Economic benefits Health policy Immunization Prescription drug costs Return on investment Vaccines global health

医学主题词费用效益分析(Cost-Benefit Analysis);发展中国家(Developing Countries);人类(Humans);免疫法(Immunization);免疫接种规划(Immunization Programs);收入(Income);接种(Vaccination)

DOI 10.1377/hlthaff.2020.00103

PMID 32744930

发布时间 2025-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交